(113 days)
No
The summary describes a physical medical device (nasogastric tube) and does not mention any software, algorithms, or AI/ML capabilities.
Yes
The device is used to evacuate the stomach of various substances in patients with medical conditions like pancreatitis and peptic ulcer, which are therapeutic interventions.
No
This device, a nasogastric tube, is used to evacuate the stomach, which is a therapeutic or management function, not a diagnostic one. It doesn't analyze physiological data or provide information to diagnose a condition.
No
The device description clearly indicates it is a physical, sterile, disposable nasogastric tube made of medical grade vinyl with various physical components like ports, a vent tube, and a stylet. This is a hardware device, not software.
Based on the provided information, the Andersen® Nasogastric Tube is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use describes a device used to evacuate the stomach of fluids and air in a patient. This is a therapeutic and diagnostic procedure performed directly on the patient's body, not on a sample taken from the body.
- Device Description: The device is a tube designed for insertion into the body. IVD devices are typically reagents, instruments, or systems used to examine specimens (like blood, urine, or tissue) in vitro (outside the body) to provide information for diagnosis, monitoring, or treatment.
- Lack of IVD Characteristics: There is no mention of analyzing samples, using reagents, or performing tests on biological specimens.
Therefore, the Andersen® Nasogastric Tube is a medical device used for a clinical procedure, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Andersen® Nasogastric Tube is indicated in those situations where the physician desires to keep the stomach continuously and completely evacuated of swallowed air, swallowed saliva, gastric secretions or fresh blood in a fasting patient for a prolonged period, such as pancreatitis, cholecystitis, post-operative ileus and non-operative management of peptic ulcer. It is also indicated to keep the stomach evacuated of fresh blood once clots have been removed.
Product codes
78 KNT
Device Description
Sterile, disposable, bilumenal, medical grade vinyl nasogastric tube with radiopaque vent tube, 24 round aspirating ports, and anti-reflux filter. Includes a lubricated polyethylene stylet. The tubes are marked to aid in positioning the tube during passage.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
stomach
Indicated Patient Age Range
Not Found
Intended User / Care Setting
physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
No new risks were added by the modification. In support of this Special 510(k), Andersen Products, Inc. has provided a declaration of conformity to 21 CFR § 820.30 Design Control requirements.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 876.5980 Gastrointestinal tube and accessories.
(a)
Identification. A gastrointestinal tube and accessories is a device that consists of flexible or semi-rigid tubing used for instilling fluids into, withdrawing fluids from, splinting, or suppressing bleeding of the alimentary tract. This device may incorporate an integral inflatable balloon for retention or hemostasis. This generic type of device includes the hemostatic bag, irrigation and aspiration catheter (gastric, colonic, etc.), rectal catheter, sterile infant gavage set, gastrointestinal string and tubes to locate internal bleeding, double lumen tube for intestinal decompression or intubation, feeding tube, gastroenterostomy tube, Levine tube, nasogastric tube, single lumen tube with mercury weight balloon for intestinal intubation or decompression, and gastro-urological irrigation tray (for gastrological use).(b)
Classification. (1) Class II (special controls). The barium enema retention catheter and tip with or without a bag that is a gastrointestinal tube and accessory or a gastronomy tube holder accessory is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I (general controls) for the dissolvable nasogastric feed tube guide for the nasogastric tube. The class I device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 876.9.
0
AUG 3 0 2002
י
510 (k) Summary
……………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………
| Trade Name | Andersen® Nasogastric Tube with Stylet (AN 11S, 13S, 14S and
18S) |
|---------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Manufacturer | Andersen Products, Inc. 3202 Caroline Drive Haw River, NC 27258 |
| Device Generic
Name | Nasogastric tube |
| Classification | Nasogastric tubes have been classified as Class II. No performance
standards have been established under Section 514 of the Food, Drug
and Cosmetic Act for gastrointestinal tubes. |
| Predicate
Device | Andersen® Nasogastric Tube with Stylet (AN 10S), K935688 |
| Device
Description | Sterile, disposable, bilumenal, medical grade vinyl nasogastric tube
with radiopaque vent tube, 24 round aspirating ports, and anti-reflux
filter. Includes a lubricated polyethylene stylet. The tubes are
marked to aid in positioning the tube during passage. |
| Indications for
Use | The Andersen® Nasogastric Tube is indicated in those situations
where the physician desires to keep the stomach continuously and
completely evacuated of swallowed air, swallowed saliva, gastric
secretions or fresh blood in a fasting patient for a prolonged period,
such as pancreatitis, cholecystitis, post-operative ileus and non-
operative management of peptic ulcer. It is also indicated to keep the
stomach evacuated of fresh blood once clots have been removed. |
| Safety and
Performance | No new risks were added by the modification. In support of this
Special 510(k), Andersen Products, Inc. has provided a declaration of
conformity to 21 CFR § 820.30 Design Control requirements. |
| Conclusion | Based on the indications for use and comparison to its predicate
device, the Andersen® Nasogastric Tube with Stylet has been shown
to be safe and effective for its intended use. |
.
1
Image /page/1/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three lines forming its body and wings. The eagle is facing right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.
AUG 3 0 2002
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Ms. Wendy Hedrick Director Quality Assurance/Regulatory Affairs Andersen Products. Inc. Health Science Park 3202 Caroline Drive HAW RIVER NC 27258
Re: K021493 Trade/Device Name: Andersen Nasogastric Tube with Stylet (AN 11S, 13S, 14S and 18S) Regulation Number: 21 CFR §876.5980 Regulation Name: Gastrointestinal tube and accessories Regulatory Class: II
Dated: July 29, 2002 Received: July 31, 2002
Product Code: 78 KNT
Dear Ms. Hedrick:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.
MP
2
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:
| 8xx.1xxx | (301) 594-4591 |
|---|---|
| 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 |
| 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 |
| 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 |
| Other | (301) 594-4692 |
Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
Nancy C Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
Indications for Use Statement
.
| 510(k) Number | K021493 |
|---|---|
| Device Name | Andersen® Nasogastric Tube with Stylet (AN 11S, 13S, 14S and 18S) |
| Indications for Use | The Andersen® Nasogastric Tube is indicated in those situations where the physician desires to keep the stomach continuously and completely evacuated of swallowed air, swallowed saliva, gastric secretions or fresh blood in a fasting patient for a prolonged period, such as pancreatitis. cholecyctitis, post-operative ileus and non-operative management of peptic ulcer. It is also indicated to keep the stomach evacuated of fresh blood once clots have been removed. |
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescription Use | ✓ | OR | Over-The-Counter Use | |
|---|---|---|---|---|
| (Per 21 CFR § 801. 109) |
Nancy Brogdon
(Division Sign-Off)
Division of Reproductive, Abdominal, and Radiological Devices
| 510(k) Number | K021493 |
|---|---|
| --------------- | --------------------------------------------------------- |